[EN] COMPOUNDS COMPRISING A CYCLOBUTOXY GROUP<br/>[FR] COMPOSÉS COMPRENANT UN GROUPE CYCLOBUTOXY
申请人:UCB PHARMA SA
公开号:WO2009092764A1
公开(公告)日:2009-07-30
The present invention relates to compounds of formula (I) comprising a cyclobutoxy group, processes for preparing them, pharmaceutical compositions comprising said compounds and their use as pharmaceuticals.
Arylthioamides as H<sub>2</sub>S Donors: <scp>l</scp>-Cysteine-Activated Releasing Properties and Vascular Effects in Vitro and in Vivo
作者:Alma Martelli、Lara Testai、Valentina Citi、Alice Marino、Isabella Pugliesi、Elisabetta Barresi、Giulia Nesi、Simona Rapposelli、Sabrina Taliani、Federico Da Settimo、Maria C. Breschi、Vincenzo Calderone
DOI:10.1021/ml400239a
日期:2013.10.10
A small library of arylthioamides 1-12 was easily synthesized, and their H2S-releasing properties were evaluated both in the absence or in the presence of an organic thiol such as L-cysteine. A number of arylthioamides (1-3 and 7) showed a slow and L-cysteine-dependent H2S-releasing mechanism, similar to that exhibited by the reference slow H2S-releasing agents, such as diallyl disulfide (DADS) and the phosphinodithioate derivative GYY 4137. Compound 1 strongly abolished the noradrenaline-induced vasoconstriction in isolated rat aortic rings and hyperpolarized the membranes of human vascular smooth muscle cells in a concentration-dependent fashion. Finally, a significant reduction of the systolic blood pressure of anesthetized normotensive rats was observed after its oral administration. Altogether these results highlighted the potential of arylthioamides 1-3 and 7 as H2S-donors for basic studies, and for the rational design/development of promising pharmacotherapeutic agents to treat cardiovascular diseases.
Compounds Comprising A Cyclobutoxy Group
申请人:Denonne Frédéric
公开号:US20100292188A1
公开(公告)日:2010-11-18
The present invention relates to compounds of formula (I) comprising a cyclobutoxy group, processes for preparing them, pharmaceutical compositions comprising said compounds and their use as pharmaceuticals.